Recent questions tagged fda

0 votes

0 answers 61 views

Prescription Drug Promotion Research -- FDA invites comments on proposed tradeoff analysis (by 6/24)

asked 26 days ago by Andrew Reamer (21.9k points)

0 votes

0 answers 110 views

FDA Quality Metrics Reporting Program -- comments invited on proposed changes (by 6/7)

asked 2 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 127 views

Drug Supply Chain Security Act -- FDA invites comment on 2 draft rules on wholesale distributors (by 4/5, 6/6)

asked 3 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 142 views

Drug Supply Chain Security Act illegitimate product notification - FDA invites comments to OMB on proposal (by 2/25)

asked 3 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 107 views

FDA Guidance for Industry: Data Standards for Drug/Biological Product Submissions -- comments on draft invited (by 2/4)

asked 4 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 115 views

FDA Guidance for Industry on Use of EHRs/Med Claims to Support Reg Decisions -- comments invited on draft (by 1/24)

asked 5 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 151 views

FDA Guidance for Industry on Use of Data/Evidence to Support Reg Decisions -- comments invited on draft (by 3/9)

asked 5 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 215 views

FDA Guidance for Industry on Assessing Registries to Support Reg Decisions -- comments invited on draft (by 2/28)

asked 5 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 123 views

Enhancing Safety/Security of Pharma Distribution Supply Chain -- FDA public mtg (11/16), seeks comments (by 1/18)

asked 7 months ago by Andrew Reamer (21.9k points)

0 votes

0 answers 228 views

Health economists -- FDA Office of Women's Health seeks input on strategic research priorities (by 9/8)

asked 1 year ago by Andrew Reamer (21.9k points)

To see more, click for the full list of questions or popular tags.

...